WALTHAM, Mass., Feb. 28, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), today announced its fourth quarter and full year 2024 financial results and business highlights.
Apellis Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results
Seeking Alpha / 15 minutes from now 2 Views
Comments